(Q34542304)

2 August 2017

title

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays (English)

1 reference

2 August 2017

18

Allan Hildesheim

0 references

Sholom Wacholder

7

Sholom Wacholder

0 references

Leen-Jan van Doorn

16

Leen-Jan van Doorn

0 references

Ana Cecilia Rodríguez

5

Ana Cecilia Rodriguez

0 references

Mahboobeh Safaeian

19

Mahboobeh Safaeian

0 references

Arpita Ghosh

Arpita Ghosh

2

0 references

Nicolas Wentzensen

11

Nicolas Wentzensen

1 reference

2 August 2017

6

Mark Schiffman

1 reference

2 August 2017

17

Rolando Herrero

1 reference

2 August 2017

Carolina Vargas-Porras

3

Carolina Porras

1 reference

Costa Rican Vaccine Trial Group

2 August 2017

20

Costa Rican Vaccine Trial Group

1 reference

2 August 2017

12

Mark T Esser

1 reference

2 August 2017

13

Katie Matys

1 reference

2 August 2017

15

Wim Quint

1 reference

2 August 2017

9

Ligia A Pinto

1 reference

2 August 2017

Shih-Wen Lin

1

1 reference

2 August 2017

Sarah C Markt

4

1 reference

2 August 2017

Troy J Kemp

8

1 reference

2 August 2017

Paula Gonzalez

10

1 reference

2 August 2017

Ariane Meuree

14

1 reference

2 August 2017

language of work or name

English

0 references

publication date

2 January 2013

1 reference

2 August 2017

1 reference

2 August 2017

volume

8

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

e53067

1 reference

Creative Commons CC0 License

2 August 2017

copyright license

start time

2 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Measuring serum antibody to human papillomavirus following infection or vaccination.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

IMMUNIZATION OF RABBITS TO INFECTIOUS PAPILLOMATOSIS.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Clinician's guide to human papillomavirus immunology: knowns and unknowns

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Interaction of human papillomaviruses with the host immune system: a well evolved relationship.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Chapter 5: Updating the natural history of HPV and anogenital cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

The causal relation between human papillomavirus and cervical cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3534652

The use of human papillomavirus seroepidemiology to inform vaccine policy

7 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053067

Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053067

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053067

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053067

Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053067

Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23301022

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human papillomavirus vaccines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23301022

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0053067

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference